Hypersensitivity reactions to transcatheter chemoembolization with cisplatin and lipiodol suspension for unresectable hepatocellular carcinoma

Journal of Vascular and Interventional Radiology

Volumn 21, Issue 8, 2010, Pages 1219-1225

  Kawaoka, Tomokazu ^a   Aikata, Hiroshi ^a   Katamura, Yoshio ^a   Takaki, Shintaro ^a   Waki, Koji ^a   Hiramatsu, Akira ^a   Takahashi, Shoichi ^a   Hieda, Masashi ^a   Kakizawa, Hideaki ^a   Chayama, Kazuaki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

HCC; hepatocellular carcinoma; Ig; immunoglobulin

Indexed keywords

ALPHA FETOPROTEIN; CISPLATIN; DECARBOXYPROTHROMBIN; IODINATED POPPYSEED OIL; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BRONCHOSPASM; CHEMOEMBOLIZATION; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUSNESS LEVEL; DRUG HYPERSENSITIVITY; DYSPNEA; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HYPOTENSION; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PRURITUS; RETROSPECTIVE STUDY; URTICARIA; CARCINOMA, HEPATOCELLULAR; JAPAN; LIVER NEOPLASMS; MIDDLE AGED; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CISPLATIN; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; IODIZED OIL; JAPAN; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 77955715993     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2010.04.014     Document Type: Article

References (38)

1. S.D. Taylor-Robinson, G.R. Foster, S. Arora, S. Hargreaves, and H.C. Thomas Increase in primary liver cancer in the UK, 197994 Lancet 350 1997 1142 1143
2. H.B. El-Serag, and A.C. Mason Rising incidence of hepatocellular carcinoma in the United States N Engl J Med 340 1999 745 750
3. K. Okita Management of hepatocellular carcinoma in Japan J Gastroenterol 41 2006 100 106
4. H.M. Goldstein, S. Wallace, J.H. Anderson, R.L. Bree, and C. Gianturco Transcatheter occlusion of abdominal tumors Radiology 120 1976 539 545
5. R. Yamada, M. Sato, M. Kawabata, H. Nakatsuka, K. Nakamura, and S. Takashima Hepatic artery embolization in 120 patients with unresectable hepatoma Radiology 148 1983 397 401
6. K. Nakakuma, S. Tashiro, and T. Hiraoka Studies on anticancer treatment with an oily anticancer drug injected into the ligated feeding hepatic artery for liver cancer Cancer 52 1983 2193 2200
7. T. Konno, H. Maeda, and K. Iwai Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report Eur J Cancer Clin Oncol 19 1983 1053 1065
8. T. Beppu, C. Ohara, and Y. Yamaguchi A new approach to chemoembolization for unresectable hepatocellular carcinoma using aclarubicin microspheres in combination with cisplatin suspended in iodized oil Cancer 68 1991 2555 2560
9. H. Kasugai, J. Kojima, and M. Tatsuta Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil Gastroenterology 97 1989 965 971
10. T. Nishizaki, K. Takenaka, K. Yoshida, T. Ikeda, and K. Sugimachi Influence of lipiodolization on a cirrhotic liver J Surg Oncol 58 1995 263 268
11. H. Ohishi, H. Uchida, and H. Yoshimura Hepatocellular carcinoma detected by iodized oil Use of anticancer agents Radiology 154 1985 25 29
12. K. Takayasu, Y. Shima, and Y. Muramatsu Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents Radiology 163 1987 345 351
13. H. Nakamura, T. Hashimoto, H. Oi, and S. Sawada Transcatheter oily chemoembolization of hepatocellular carcinoma Radiology 170 1989 783 786 (Pubitemid 19062602)
14. Y. Sasaki, S. Imaoka, and H. Kasugai A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge Cancer 60 1987 1194 1203
15. J. Shibata, S. Fujiyama, T. Sato, S. Kishimoto, S. Fukushima, and M. Nakano Hepatic arterial injection chemotherapy with cisplatin suspended in an oily lymphographic agent for hepatocellular carcinoma Cancer 64 1989 1586 1594
16. H. Abe, K. Kubota, T. Oka, T. Kobayashi, and M. Makuuchi A rare case of multiple carcinoids and endocrine cell micronests in a patient with chronic duodenitis Cancer 89 2000 963 969
17. K. Ueno, N. Miyazono, H. Inoue, H. Nishida, I. Kanetsuki, and M. Nakajo Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors Cancer 88 2000 1574 1581
18. K. Ikeda, H. Kumada, S. Saitoh, Y. Arase, and K. Chayama Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma An analysis by the Cox proportional hazard model Cancer 68 1991 2150 2154
19. B. Solomon, M.C. Soulen, R.A. Baum, Z.J. Haskal, R.D. Shlansky-Goldberg, and C. Cope Chemoembolization of hepatocellular carcinoma with cisplatin, doxorubicin, mitomycin-C, Ethiodol, and polyvinyl alcohol: prospective evaluation of response and survival in a U.S. population J Vasc Interv Radiol 10 1999 793 798
20. M.F. Yuen, A.O. Chan, and B.C. Wong Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients Am J Gastroenterol 98 2003 1181 1185
21. T. Araki, T. Hihara, and K. Kachi Newly developed transarterial chemoembolization material: CDDP-Lipiodol suspension Gastrointest Radiol 14 1989 46 48
22. H. Ngan, C.L. Lai, S.T. Fan, E.C. Lai, W.K. Yuen, and W.K. Tso Treatment of inoperable hepatocellular carcinoma by transcatheter arterial chemoembolization using an emulsion of cisplatin in iodized oil and Gelfoam Clin Radiol 47 1993 315 320
23. K. Yamamoto, T. Shimizu, and I. Narabayashi Intraarterial infusion chemotherapy with lipiodol-CDDP suspension for hepatocellular carcinoma Cardiovasc Intervent Radiol 23 2000 26 39
24. T. Kawaoka, H. Aikata, and S. Takaki Transarterial infusion chemotherapy using cisplatin-lipiodol suspension with or without embolization for unresectable hepatocellular carcinoma Cardiovasc Intervent Radiol 32 2009 687 694
25. K. Kamada, T. Nakanishi, and M. Kitamoto Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: comparison of cisplatin lipiodol suspension and doxorubicin hydrochloride emulsion J Vasc Interv Radiol 12 2001 847 854
26. D.C. Wong, and A.B. Deisseroth Successful continuation of cisplatin therapy after partial recovery from acute renal failure Cancer Treat Rep 69 1985 731 733
27. B.A. Mason, J. Dambra, B. Grossman, and R.B. Catalano Effective control of cisplatin-induced nausea using high-dose steroids and droperidol Cancer Treat Rep 66 1982 243 245
28. R. Basu, A. Rajkumar, and N.R. Datta Anaphylaxis to cisplatin following nine previous uncomplicated cycles Int J Clin Oncol 7 2002 365 367
29. A.A. Shlebak, P.I. Clark, and J.A. Green Hypersensitivity and cross-reactivity to cisplatin and analogues Cancer Chemother Pharmacol 35 1995 349 351
30. The general rules for the clinical and pathological study of primary liver cancer Liver Cancer Study Group of Japan Jpn J Surg 19 1989 98 129
31. J.F. Cardella, S. Kundu, D.L. Miller, S.F. Millward, and D. Sacks Society of Interventional Radiology clinical practice guidelines J Vasc Interv Radiol 20 Suppl 2009 S189 S191
32. R.B. Weiss, and S. Bruno Hypersensitivity reactions to cancer chemotherapeutic agents Ann Intern Med 94 1981 66 72
33. M. Markman, A. Kennedy, and K. Webster Clinical features of hypersensitivity reactions to carboplatin J Clin Oncol 17 1999 1141
34. A. Goldberg, M.M. Altaras, Y.A. Mekori, Y. Beyth, and R. Confino-Cohen Anaphylaxis to cisplatin: diagnosis and value of pretreatment in prevention of recurrent allergic reactions Ann Allergy 73 1994 271 272
35. S. Zweizig, L.D. Roman, and L.I. Muderspach Death from anaphylaxis to cisplatin: a case report Gynecol Oncol 53 1994 121 122
36. C. Ciesielski-Carlucci, P. Leong, and C. Jacobs Case report of anaphylaxis from cisplatin/paclitaxel and a review of their hypersensitivity reaction profiles Am J Clin Oncol 20 1997 373 375
37. J. Charles, P. Travers, and M. Walport Immunobiology fifth edition 2001 Garland Science London 101 153
38. O. Cromwell, J. Pepys, W.E. Parish, and E.G. Hughes Specific IgE antibodies to platinum salts in sensitized workers Clin Allergy 9 1979 109 117